150 related articles for article (PubMed ID: 15082202)
41. [Prophylactic effect of etretinate on the recurrence of superficial bladder tumors--results of a randomized control study].
Yoshida O; Miyakawa M; Watanabe H; Mishina T; Okajima E; Hirao Y; Matushima M; Nihira H; Nakatsu H
Hinyokika Kiyo; 1986 Sep; 32(9):1349-58. PubMed ID: 3544744
[TBL] [Abstract][Full Text] [Related]
42. [Combination chemotherapy of mitomycin C and cytosine arabinoside in superficial bladder tumors. 1. Evaluation of intravesical infusion therapy].
Ikeuchi T; Onodera Y; Kai Y
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2145-51. PubMed ID: 6414383
[TBL] [Abstract][Full Text] [Related]
43. A prospective randomized study of prophylaxis of tumor recurrence following transurethral resection of superficial bladder cancer--intravesical thio-TEPA versus oral UFT.
Hirao Y; Okajima E; Ozono S; Samma S; Sasaki K; Hiramatsu T; Babaya K; Watanabe S; Maruyama Y
Cancer Chemother Pharmacol; 1992; 30 Suppl():S26-30. PubMed ID: 1394812
[TBL] [Abstract][Full Text] [Related]
44. Experiences on the local adriamycin treatment of bladder tumours.
Somogyi L; Török A; Bors G; Frang D
Acta Chir Hung; 1987; 28(2):79-85. PubMed ID: 3618056
[TBL] [Abstract][Full Text] [Related]
45. Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).
Tolley DA; Hargreave TB; Smith PH; Williams JL; Grigor KM; Parmar MK; Freedman LS; Uscinska BM
Br Med J (Clin Res Ed); 1988 Jun; 296(6639):1759-61. PubMed ID: 3136828
[TBL] [Abstract][Full Text] [Related]
46. Absorption of epi-doxorubicin after intravesical administration in patients with in situ transitional cell carcinoma of the bladder.
Mross K; Maessen P; van der Vijgh WJ; Bogdanowicz JF; Kurth KH; Pinedo HM
Eur J Cancer Clin Oncol; 1987 May; 23(5):505-8. PubMed ID: 3477456
[TBL] [Abstract][Full Text] [Related]
47. The role of intravesical thiotepa in the management of superficial bladder cancer. National Bladder Cancer Collaborative Group A.
Cancer Res; 1977 Aug; 37(8 Pt 2):2916-7. PubMed ID: 406040
[TBL] [Abstract][Full Text] [Related]
48. Intravesical instillation of mitomycin C in the prophylactic treatment of recurring superficial transitional cell carcinoma of the bladder.
Devonec M; Bouvier R; Sarkissian J; Bendimerad O; Gelet A; Dubernard JM
Br J Urol; 1983 Aug; 55(4):382-5. PubMed ID: 6411163
[TBL] [Abstract][Full Text] [Related]
49. Intravesical epirubicin with and without verapamil for the prophylaxis of superficial bladder tumours.
Lukkarinen O; Paul C; Hellström P; Kontturi M; Nurmi M; Puntala P; Ottelin J; Tammela T; Tidefeldt U
Scand J Urol Nephrol; 1991; 25(1):25-8. PubMed ID: 2047768
[TBL] [Abstract][Full Text] [Related]
50. A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers.
Flanigan RC; Ellison MF; Butler KM; Gomella LG; McRoberts JW
J Urol; 1986 Jul; 136(1):35-7. PubMed ID: 3086575
[TBL] [Abstract][Full Text] [Related]
51. [Phase II collaborative study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) for urological malignancies--Urological Co-operative THP Study Group].
Niijima T; Koyanagi T; Sakashita S; Origasa S; Akaza H; Machida T; Koiso K; Rinsho K; Aso Y; Suzuki K
Gan To Kagaku Ryoho; 1986 Feb; 13(2):224-31. PubMed ID: 3947104
[TBL] [Abstract][Full Text] [Related]
52. Intravesical therapy with adriamycin plus verapamil in patients with superficial bladder cancer: a pilot study.
Naito S; Kimiya K; Ueda T; Kumazawa J; Omoto T; Osada Y; Iguchi A; Ariyoshi A; Sagiyama K
Urol Int; 1992; 48(3):270-3. PubMed ID: 1589915
[TBL] [Abstract][Full Text] [Related]
53. [Evaluation of the efficacy of intravesical cisplatin in superficial bladder tumors].
Ojea A; Nogueira March JL; Figueiredo L; Jamardo D; Pérez Villanueva J
Actas Urol Esp; 1984; 8(3):217-20. PubMed ID: 6540971
[No Abstract] [Full Text] [Related]
54. How effective is topical alpha-2b interferon in preventing recurrence of superficial bladder cancer?
Hoeltl W; Hasun R; Albrecht W; Marberger M
Br J Urol; 1991 Nov; 68(5):495-8. PubMed ID: 1747725
[TBL] [Abstract][Full Text] [Related]
55. Intravesical chemoresection with 4'-epi-doxorubicin in patients with superficial bladder tumors.
Calais da Silva F; Denis L; Bono A; Bollack C; Bouffioux C
Eur Urol; 1988; 14(3):207-9. PubMed ID: 3289935
[TBL] [Abstract][Full Text] [Related]
56. [Oral chemoprophylaxis with ftorafur against the recurrence of superficial bladder tumors].
Lancina Martín JA; García Pérez M; Arrabal Martín M; Camacho Martínez E
Arch Esp Urol; 1988; 41(6):431-3. PubMed ID: 3148297
[No Abstract] [Full Text] [Related]
57. Intravesical therapy with adriamycin and 4-epirubicin for superficial bladder cancer: the experience of the EORTC GU Group.
van der Meijden AP; Kurth KH; Oosterlinck W; Debruyne FM
Cancer Chemother Pharmacol; 1992; 30 Suppl():S95-8. PubMed ID: 1394828
[TBL] [Abstract][Full Text] [Related]
58. Phase 1/2 study of intravesical epirubicin in patients with carcinoma in situ of the bladder.
Kurth K; Vijgh WJ; ten Kate F; Bogdanowicz JF; Carpentier PJ; Van Reyswoud I
J Urol; 1991 Dec; 146(6):1508-12; discussion 1512-3. PubMed ID: 1942329
[TBL] [Abstract][Full Text] [Related]
59. Intravesical chemotherapy with 4'-epi-Adriamycin in patients with superficial bladder tumors.
Matsumura Y; Tsushima T; Ozaki Y; Yoshimoto J; Akagi T; Obama T; Nasu Y; Ohmori H
Cancer Chemother Pharmacol; 1986; 16(2):176-7. PubMed ID: 3456282
[TBL] [Abstract][Full Text] [Related]
60. Chemoimmunotherapy for prophylaxis of recurrence in superficial bladder cancer: interferon-alpha 2b versus interferon-alpha 2b with epirubicin.
Ferrari P; Castagnetti G; Pollastri CA; Ferrari G; Tavoni F; Grassi D
Anticancer Drugs; 1992 May; 3 Suppl 1():25-7. PubMed ID: 1611113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
